DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

Gilead Sciences (NASDAQ: GILD)

107.41 1.14 (1.07%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $107.41 1.07%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $106.55
Previous Close $106.27
Daily Range $105.76 - $108.77
52-Week Range $58.50 - $108.77
Market Cap $162.4B
P/E Ratio 23.93
Dividend (Yield) $0.00 (0.0%)
Volume 16,160,275
Average Daily Volume 13,592,380
Current FY EPS $7.26

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Is It Time to Buy AbbVie Stock?

A multi-billion dollar acquisition is in the works with huge potential tax savings. Is now the right time to buy AbbVie stock?

Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog

Kite Pharma (KITE) Shows Strength: Stock Rises 17.7% - Tale of the Tape

3 Drugs Stocks On The Rise

S&P 2,000: Speed Bump Or Top?

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

Roche, InterMune a Strategic Play in Midst of Inversions

Gilead Sciences: Due For More Short Squeezing?

See More GILD News...

GILD's Top Competitors

GILD $107.41 (1.07%)
Current stock: GILD
AMGN $137.83 (0.41%)
Current stock: AMGN
CELG $94.74 (-0.96%)
Current stock: CELG
$0.00 (0.00%)
Current stock: